India, Sept. 9 -- Femasys Inc. (FEMY) announced a partnership with CapexMD to expand patient access to its FemaSeed-led fertility portfolio through dedicated financing solutions.
The collaboration is intended to help reduce financial barriers to fertility care across OB/GYN practices and fertility centers.
The financing program will support access to FemaSeed Complete, an in-office intratubal insemination solution designed as a first-line fertility treatment.
The partnership will also support access to Femasys' female and male fertility diagnostic products, including FemVue and SpermVue.
Femasys said FemaSeed is designed to provide patients with a first-line fertility treatment option at a lower cost than in-vitro fertilization (IVF), a...